Inhibition of C6 glioma cell proliferation by anandamide, 1-arachidonoylglycerol, and by a water soluble phosphate ester of anandamide: Variability in response and involvement of arachidonic acid

Biochemical Pharmacology

Volumn 66, Issue 5, 2003, Pages 757-767

  Fowler, Christopher J ^a   Jonsson, Kent Olov ^a   Andersson, Anna ^a   Juntunen, Juha ^b   Järvinen, Tomi ^b   Vandevoorde, Séverine ^c   Lambert, Didier M ^c   Jerman, Jeffrey C ^d   Smart, Darren ^d  

^a UMEÅ UNIVERSITY   (Sweden)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

^c UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^d GLAXOSMITHKLINE   (United Kingdom)

Author keywords

1 Arachidonoylglycerol; 2 Arachidonoylglycerol; Anandamide; Cannabinoid receptors; Cell proliferation; SB366791; Vanilloid receptors

Indexed keywords

1 ARACHIDONOYLGLYCEROLGLYCEROL; ANANDAMIDE; ANTINEOPLASTIC AGENT; ARACHIDONIC ACID; ARACHIDONIC ACID DERIVATIVE; CALCIUM ION; CANNABINOID RECEPTOR ANTAGONIST; CAPSAZEPINE; ESTER DERIVATIVE; FATTY ACID AMIDASE; GLYCEROL DERIVATIVE; HYDROLASE INHIBITOR; KETONE DERIVATIVE; METHANANDAMIDE; N (3 METHOXYPHENYL) 4 CHLOROCINNAMANILIDE; ORGANOPHOSPHATE; PALMITOYLETHYLAMIDE; PHOSPHOLIPASE A2; RECEPTOR BLOCKING AGENT; SB 366791; UNCLASSIFIED DRUG; VANILLOID RECEPTOR;

ANIMAL CELL; ARTICLE; CALCIUM TRANSPORT; CANCER INHIBITION; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG MECHANISM; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG SOLUBILITY; EMBRYO; ENZYME INHIBITION; FIBROBLAST; GLIOMA CELL; HUMAN; HUMAN CELL; HYDROLYSIS; METASTASIS INHIBITION; MODEL; NONHUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; RAT;

EID: 0042431524     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(03)00392-7     Document Type: Article

References (54)

1. Pertwee R. The evidence for the existence of cannabinoid receptors. Gen. Pharmacol. 24:1993;811-824.
2. Howlett A.C., Barth F., Bonner T.I., Cabral G., Casellas P., Devane W.A., Felder C.C., Herkenham M., Mackie K., Martin B.R., Mechoulam R., Pertwee R.G. International union of pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol. Rev. 54:2002;161-202.
3. Devane W.A., Hanus L., Breuer A., Pertwee R.G., Stevenson L.A., Griffin G., Gibson D., Mandelbaum A., Etinger A., Mechoulam R. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science. 258:1992;1946-1949.
4. Zygmunt P.M., Petersson J., Andersson D.A., Chuang H.-H., Sørgård M., Di Marzo V., Julius D., Högestätt E.D. Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature. 400:1999;452-457.
5. Smart D., Gunthorpe M.J., Jerman J.C., Nasir S., Gray J., Miur A.I., Chambers J.K., Randall A.D., Davis J.B. The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1). Br. J. Pharmacol. 129:2000;227-230.
6. Sugiura T., Kondo S., Sukgawa A., Nakane S., Shinoda A., Itoh K., Yamashita A., Waku K. 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. Biochem. Biophys. Res. Commun. 215:1995;89-97.
7. 1 receptor. Proc. Natl. Acad. Sci. U.S.A. 98:2001;3662-3665.
8. Bifulco M., Di Marzo V. Targeting the endocannabinoid system in cancer therapy: a call for further research. Nat. Med. 8:2002;547-550.
9. Parolaro D., Massi P., Rubino T., Monti E. Endocannabinoids in the immune system and cancer. Prostagl. Leukotr. Ess. Fatty Acids. 66:2002;319-332.
10. Maccarrone M., Lorenzon T., Bari M., Melino G., Finazzi-Agrò A. Anandamide induces apoptosis in human cells via vanilloid receptors. Evidence for a protective role of cannabinoid receptors. J. Biol. Chem. 275:2000;31938-31945.
11. Jacobsson S.O.P., Wallin T., Fowler C.J. Inhibition of rat C6 glioma cell proliferation by endogenous and synthetic cannabinoids. Relative involvement of cannabinoid and vanilloid receptors. J. Pharmacol. Exp. Ther. 299:2001;951-959.
12. 9-Tetrahydrocannabinol stimulates glucose utilization in C6 glioma cells. Brain Res. 436:1997;64-71.
13. Bíró T., Brodie C., Modarres S., Lewin N.E., Ács P., Blumberg P.M. Specific vanilloid responses in C6 rat glioma cells. Mol. Brain Res. 56:1998;89-98.
14. 9-Tetrahydrocannabinol induces apoptosis in C6 glioma cells. FEBS Letts. 436:1998;6-10.
15. Bisogno T., Maccarrone M., De Petrocellis L., Jarrahian A., Finazzi-Agrò A., Hillard C., Di Marzo V. Eur. J. Biochem. 268:2001;1982-1989.
16. Abadji V., Lin S., Taha G., Griffin G., Stevenson L.A., Pertwee R.G., Makriyannis A. (R)-Methanandamide: a chiral novel anandamide possessing higher potency and metabolic stability. J. Med. Chem. 37:1994;1889-1893.
17. Ralevic V., Kendall D.A., Jerman J.C., Middlemiss D.N., Smart D. Cannabinoid activation of recombinant and endogenous vanilloid receptors. Eur. J. Pharmacol. 424:2001;211-219.
18. Ross R.A., Gibson T.M., Brockie H.C., Leslie M., Pashmi G., Craib S.J., Di Marzo V., Pertwee R.G. Structure-activity relationship for the endogenous cannabinoid, anandamide, and certain of its analogues at vanilloid receptors in transfected cells and vas deferens. Br. J. Pharmacol. 132:2001;631-640.
19. De Petrocellis L., Bisogno T., Davis J.B., Pertwee R.G., Di Marzo V. Overlap between the ligand recognition properties of the anandamide transporter and the VR1 vanilloid receptor: inhibitors of anandamide uptake with negligible capsaicin-like activity. FEBS Letts. 483:2000;52-56.
20. Jonsson K.-O., Andersson A., Jacobsson S.O.P., Vandevoorde S., Lambert D.M., Fowler C.J. AM404 and VDM11 non-specifically inhibit C6 glioma cell proliferation at concentrations used to block the cellular accumulation of the endocannabinoid anandamide. Arch. Toxicol. 77:2003;201-207.
21. Garle M.J., Knight A., Downing A.T., Jassi K.K.L., Clothier R.H., Fry J.R. Stimulation of dichlorofluorescin oxidation by capsaicin and analogues in RAW 264 monocyte/macrophages: lack of involvement of the vanilloid receptor. Biochem. Pharmacol. 59:2000;563-572.
22. 1 receptor-dependent G-protein activation in rat cerebellar membranes. Br. J. Pharmacol. 134:2001;664-672.
23. Rouzer C.A., Ghebreselasie K., Marnett L.J. Chemical stability of 2-arachidonoylglycerol under biological conditions. Chem. Phys. Lipids. 119:2002;69-82.
24. Lang W., Qin C., Lin S., Khanolkar A.D., Goutopoulos A., Fan P., Abouzid K., Meng Z., Biegel D., Makriyannis A. Substrate specificity and stereoselectivity of rat brain microsomal anandamide amidohydrolase. J. Med. Chem. 42:1999;896-902.
25. Davis J.B., Gunthorpe M.J., Jerman J.C., Gray J., Smith G.D., Davies C.H., Randall A.D., Smart D., Rami H.K., Wyman P.A. Identification of a potent and selective antagonist of vanilloid receptor-1, SB366791. Soc. Neurosci. Abstr. 27:2001;910.5.
26. Sheskin T., Hanus L., Slager J., Vogel Z., Mechoulam R. Structural requirements for binding of anandamide-type compounds to the brain cannabinoid receptor. J. Med. Chem. 40:1997;659-667.
27. Juntunen J., Huuskonen J., Laine K., Niemi R., Taipale H., Nevalainen T., Pate D.W., Järvinen T. Anandamide prodrugs. 1. Water-soluble phosphate esters of arachidonylethanolamide and R-methanandamide. Eur. J. Pharm. Sci. 19:2003;37-43.
28. Smart D., Jerman J.C., Gunthorpe M.J., Brough S.J., Ranson J., Cairns W., Hayes P.D., Randall A.D., Davis J.B. Characterisation using FLIPR of human vanilloid receptor (VR1) pharmacology. Eur. J. Pharmacol. 417:2001;51-58.
29. Wood MD, Smart D. Real time receptor function in vitro: microphysiometry and FLIPR. In: Stanford CS, Horton RW, editors. Receptors: a practical approach. Oxford: Oxford University Press; 2001. p. 175-91.
30. McIntyre P., McLatchie L.M., Chambers A., Phillips E., Clarke M., Savidge J., Toms C., Peacock M., Shah K., Winter J., Weerasakera N., Webb M., Rang H.P., Bevan S., James I.F. Pharmacological differences between the human and rat vanilloid receptor 1 (VR1). Br. J. Pharmacol. 132:2001;1084-1094.
31. Deutsch D.G., Chin S.A. Enzymatic synthesis and degradation of anandamide a cannabinoid receptor agonist. Biochem. Pharmacol. 46:1993;791-796.
32. Wartmann M., Campbell D., Subramanian A., Burstein S.H., Davis R.J. The MAP kinase signal transduction pathway is activated by the endogenous cannabinoid anandamide. FEBS Letts. 359:1995;133-136.
33. Jonsson K.-O., Vandevoorde S., Lambert D.M., Tiger G., Fowler C.J. Effects of homologues and analogues of palmitoylethanolamide upon the inactivation of the endocannabinoid anandamide. Br. J. Pharmacol. 133:2001;1263-1275.
34. 2: structure-function studies with vesicle micelle and membrane assays. Biochim. Biophys. Acta. 1420:1999;45-56.
35. Smart D., Jonsson K.-O., Vandevoorde S., Lambert D.M., Fowler C.J. Entourage effects of N-acyl ethanolamines at human vanilloid receptors. Comparison of effects upon anandamide-induced vanilloid receptor activation and upon anandamide metabolism. Br. J. Pharmacol. 136:2002;452-458.
36. Galve-Roperh I., Sánchez C., Cortés M.L., Gómez del Pulgar T., Izquierdo M., Guzmán M. Anti-tumoral action of cannabinoids: involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation. Nat. Med. 6:2000;313-319.
37. Gubits R.M., Yu H., Casey G., Munell F., Vitek M.P. Altered genetic response to β-adrenergic receptor activation in late passage C6 glioma cells. J. Neurosci. Res. 22:1992;297-305.
38. + channel TASK-1. EMBO J. 20:2001;47-54.
39. Trevisani M., Smart D., Gunthorpe M.J., Tognetto M., Barbieri M., Campi B., Amadesi S., Gray J., Jerman J.C., Brough S.J., Owen D., Smith G.D., Randall A.D., Harrison S., Bianchi A., Davis J.B., Geppetti P. Ethanol elicits and potentiates nociceptor responses via the vanilloid receptor-1. Nat. Neurosci. 5:2002;546-551.
40. Hunter S.A., Burstein S.H. Receptor mediation in cannabinoid stimulated arachidonic acid mobilization and anandamide synthesis. Life Sci. 60:1997;1563-1573.
41. Goparaju S.K., Ueda N., Taniguchi K., Yamamoto S. Enzymes of porcine brain hydrolyzing 2-arachidonoylglycerol an endogenous ligand of cannabinoid receptors. Biochem. Pharmacol. 57:1999;417-423.
42. Di Marzo V., Bisogno T., De Petrocellis L., Melck D., Orlando P., Wagner J.A., Kunos G. Biosynthesis and inactivation of the endocannabinoid 2-arachidonoylglycerol in circulating and tumoral macrophages. Eur. J. Biochem. 264:1999;258-267.
43. Dinh T.P., Carpenter D., Leslie F.M., Freund T.F., Katona I., Sensi S.L., Kathuria S., Piomelli D. Brain monoglyceride lipase participating in endocannabinoid inactivation. Proc. Natl. Acad. Sci. U.S.A. 99:2002;10819-10824.
44. Staub F., Winkler A., Peters J., Goerke U., Kenmpski O., Baethmann A. Clearance and metabolism of arachidonic acid by C6 glioma cells and astrocytes. Neurochem. Res. 20:1995;1449-1456.
45. 2. Analyt. Biochem. 222:1994;110-115.
46. De Petrocellis L., Bisogno T., Maccarone M., Davis J.B., Finazzi-Agrò A., Di Marzo V. The activity of anandamide at vanilloid VR1 receptors requires facilitated transport across the cell membrane and is limited by intracellular metabolism. J. Biol. Chem. 276:2001;12856-12863.
47. Jordt S.-E., Julius D. Molecular basis for species-specific sensitivity to "hot" chili peppers. Cell. 108:2002;421-430.
48. Fowler C.J., Jacobsson S.O.P. Cellular transport of anandamide, 2-arachidonoylglycerol and palmitoylethanolamide - targets for drug development? Prostagl. Leukotr. Ess. Fatty Acids. 66:2002;193-200.
49. Patricelli M.P., Cravatt B.F. Proteins regulating the biosynthesis and inactivation of neuromodulatory fatty acid amides. Vit. Hormon. 62:2001;95-131.
50. Glaser S.T., Abumrad N., Fatade F., Kaczocha M., Studholme K.M., Deutsch D.G. Evidence against the presence of an anandamide transporter. Proc. Natl. Acad. Sci. U.S.A. 1000:2003;4269-4274.
51. Fowler C.J., Jonsson K.-O., Tiger G. Fatty acid amide hydrolase: biochemistry, pharmacology, and therapeutic possibilities for an enzyme hydrolysing anandamide, 2-arachidonoylglycerol, palmitoylethanolamide, and oleamide. Biochem. Pharmacol. 62:2001;517-526.
52. Craib S.J., Ellington H.C., Pertwee R.G., Ross R.A. A possible role of lipoxygenase in the activation of vanilloid receptors by anandamide in the guinea-pig bronchus. Br. J. Pharmacol. 134:2001;30-37.
53. Kagaya M., Lamb J., Robbins J., Page C.P., Spina D. Characterization of the anandamide induced depolarization of guinea-pig isolated vagus nerve. Br. J. Pharmacol. 137:2002;38-48.
54. Kozak K.R., Gupta R.A., Moody J.S., Ji C., Boeglin W.E., DuBois R.N., Brash A.R., Marnett L.J. 15-Lipoxygenase metabolism of 2-arachidonoylglycerol. Generation of a peroxisome proliferator-activated receptor α agonist. J. Biol. Chem. 277:2002;23278-23286.